Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-049704·Redmile Group, LLC
Schedule 13G ownership disclosure
Silence Therapeutics plc
Ordinary Shares, nominal value GBP 0.05 per share · CUSIP: G8128Y157
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Redmile Group, LLC
Shares: 6,644,841.00 · Class: 4.7%
- Jeremy C. Green
Shares: 6,644,841.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049704
- Form type
- SCHEDULE 13G/A
- Filer
- Redmile Group, LLC
- CIK
- CIK 1425738
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership